Takahashi T - Search Results

1

Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.

Mori M, Chiba R, Takahashi T. Mori M, et al. Among authors: takahashi t. Cancer. 1993 Oct 15;72(8):2331-40. doi: 10.1002/1097-0142(19931015)72:8<2331::aid-cncr2820720808>3.0.co;2-e. Cancer. 1993. PMID: 8402446

2

Frequent involvement of chromatin remodeler alterations in gastric field cancerization.

Takeshima H, Niwa T, Takahashi T, Wakabayashi M, Yamashita S, Ando T, Inagawa Y, Taniguchi H, Katai H, Sugiyama T, Kiyono T, Ushijima T. Takeshima H, et al. Among authors: takahashi t. Cancer Lett. 2015 Feb 1;357(1):328-338. doi: 10.1016/j.canlet.2014.11.038. Epub 2014 Nov 22. Cancer Lett. 2015. PMID: 25462860

3

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T. Hida T, et al. Among authors: takahashi t. Cancer Res. 1998 Sep 1;58(17):3761-4. Cancer Res. 1998. PMID: 9731479

4

p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking.

Takagi Y, Osada H, Kuroishi T, Mitsudomi T, Kondo M, Niimi T, Saji S, Gazdar AF, Takahashi T, Minna JD, Takahashi T. Takagi Y, et al. Among authors: takahashi t. Br J Cancer. 1998 May;77(10):1568-72. doi: 10.1038/bjc.1998.258. Br J Cancer. 1998. PMID: 9635830 Free PMC article.

5

In vitro effects of a recombinant toxin, mSCF-PE40, targeting c-kit receptors ectopically expressed in small cell lung cancers.

Nishida K, Seto M, Takahashi T, Oshima Y, Asano S, Tojo A, Ueda R. Nishida K, et al. Among authors: takahashi t. Cancer Lett. 1997 Feb 26;113(1-2):153-8. doi: 10.1016/s0304-3835(96)04593-4. Cancer Lett. 1997. PMID: 9065815

6

Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.

Ikarashi H, Fujita K, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K. Ikarashi H, et al. Among authors: takahashi t. Cancer Res. 1994 Jan 1;54(1):190-6. Cancer Res. 1994. PMID: 8261438

7

Lymphokine-activated killer cytotoxicity against pancreas adenocarcinoma cell lines and vascular endothelial cells.

Sugiura H, Ishikura H, Omi M, Kaji M, Iwai K, Kishimoto T, Takahashi T, Kimura C, Kato H, Yoshiki T. Sugiura H, et al. Among authors: takahashi t. Pathol Int. 1994 Sep;44(9):688-96. doi: 10.1111/j.1440-1827.1994.tb02948.x. Pathol Int. 1994. PMID: 7804431

8

Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinoembryonic antigen (CEA) and CA19-9.

Mitsuhashi N, Takahashi T, Sakurai H, Yamakawa M, Hasegawa M, Furuta M, Matsumoto H, Higuchi K, Hayakawa K, Niibe H. Mitsuhashi N, et al. Among authors: takahashi t. Lung Cancer. 1995 Mar;12(1-2):13-24. doi: 10.1016/0169-5002(94)00403-a. Lung Cancer. 1995. PMID: 7600027

9

Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.

Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H. Katoh O, et al. Among authors: takahashi t. Cancer Res. 1998 Dec 1;58(23):5565-9. Cancer Res. 1998. PMID: 9850095

10

Changes in expression of the antigen recognized by monoclonal antibody A7 in human pancreatic carcinoma cells following exposure to anticancer agents.

Yamaguchi T, Yamaoka N, Kitamura K, Otsuji E, Okamoto K, Tsuruta H, Yata Y, Takahashi T. Yamaguchi T, et al. Among authors: takahashi t. Cancer Lett. 1998 Apr 24;126(2):165-72. doi: 10.1016/s0304-3835(97)00544-2. Cancer Lett. 1998. PMID: 9585062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results